1,008 followers
We'd all agree that Orkambi isn't as good as we'd like it to be, but combination therapy is a key development. https://t.co/UCFRnmzqqf
We'd all agree that Orkambi isn't as good as we'd like it to be, but combination therapy is a key development. https://t.co/UCFRnmzqqf
#rsjc we will be starting shortly! We will start with Orkambi in #CF https://t.co/Xle8f9gQrv
#rsjc article 2 (2015 paper) but good to read https://t.co/lIQzZIFNNH too https://t.co/UewLUDAwTv
Article 2: Lumacaftor–Ivacaftor in Patients w/ Cystic Fibrosis Homozygous F508 #rsjc https://t.co/XHzhuzxxtU